PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer
PNI is an independent prognostic factor for advanced BC receiving immunotherapy and the prognostic model based on PNI has good discrimination, authenticity and consistency.
Authors
- Xiangwen Dong
- Téngfēi Zhāng (ORCID: https://orcid.org/0000-0001-5060-1486)
- Yikai Han
- Xiaodan Liu (ORCID: https://orcid.org/0000-0001-5978-299X)
- Xinyang Li (ORCID: https://orcid.org/0009-0008-7815-3994)
- Xiang Cheng (ORCID: https://orcid.org/0000-0001-9019-7246)
- Yanlong Zhang (ORCID: https://orcid.org/0000-0001-8931-2171)
- Yuan Fang (ORCID: https://orcid.org/0000-0001-6476-5334)
- Ziwen Lei
- Sarah Ren (ORCID: https://orcid.org/0009-0009-2899-7619)
Institutions
- Cangzhou Central Hospital (CN)
- Jingzhou Central Hospital (CN)
- First Affiliated Hospital of Henan University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Huanghe Science and Technology College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fonc.2025.1534545
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Zhengzhou University
- National Key Research and Development Program of China